Evaluation of Reference variability [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2009-04-17 15:44 (6275 d 12:13 ago) – Posting: # 3555
Views: 5,619

Dear Nirali,

I agree with Ohlbe. Same opinions were expressed at the EUFEPS meeting last January (see this thread), where almost the entire PK group of EMEA was present. The group univocally expressed their point of view that a two period replicate design (reference only) is not acceptable. See also Jan Welink's presentation (slide 22).
On the other hand I know of European companies running such studies right now (despite clear reservations by regulators). Obviously these companies are sure that they will be able to convince authorities that the performance was not sloppy. I would not bet on their success!

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
110 visitors (0 registered, 110 guests [including 19 identified bots]).
Forum time: 03:58 CEST (Europe/Vienna)

Competence, like truth, beauty and contact lenses,
is in the eye of the beholder.    Laurence J. Peter

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5